Gout treatment has two distinct phases: quieting the acute attack quickly with anti-inflammatory medication (colchicine, NSAIDs, or corticosteroids), and then lowering uric acid below 6 mg/dL with daily medication, usually allopurinol, so crystals dissolve and attacks stop recurring. Most gout suffering comes from doing only the first half. The flare gets treated, the cause doesn’t, and the disease quietly advances between attacks. Managed correctly, gout is one of the most controllable diseases in all of rheumatology. Most patients can become essentially flare-free. Phase 1: Stopping the Flare (Fast) Gout flares are among medicine’s most painful events. A joint (classically the big toe, but also ankle, knee, or wrist) becomes abruptly swollen, red, hot, and exquisitely tender, often overnight. Speed is the whole game: treatment begun within the first 24 hours shortens attacks dramatically.The three first-line options, chosen based on your kidneys, stomach, heart, diabetes status, and other medications:Colchicine: most effective started early; modern low-dose regimens work as well as old high-dose ones with far fewer side effects.NSAIDs (naproxen, indomethacin, celecoxib): effective at full anti-inflammatory doses; avoided with kidney disease, ulcers, or certain heart conditions.Corticosteroids: prednisone by mouth, or a steroid injection directly into the joint; often the best choice when NSAIDs and colchicine aren’t safe.Ice and elevation help. “Waiting it out” is a plan for a week of misery. Untreated flares typically last 7-14 days.One critical rule: if you’re already taking a uric-acid-lowering medication when a flare hits, don’t stop it. Stopping and restarting causes uric acid swings that prolong …
Gout Treatment: How to Stop a Flare Fast, and Lower Uric Acid So It Never Comes Back
Gout treatment has two distinct phases: quieting the acute attack quickly with anti-inflammatory medication (colchicine, NSAIDs, or corticosteroids), and then lowering uric acid below 6 mg/dL with daily medication, usually allopurinol, so crystals dissolve and attacks stop recurring. Most gout suffering comes from doing only the first half. The flare gets treated, the cause doesn’t, and the disease quietly advances between attacks. Managed correctly, gout is one of the most controllable diseases in all of rheumatology. Most patients can become essentially flare-free.
Phase 1: Stopping the Flare (Fast)
Gout flares are among medicine’s most painful events. A joint (classically the big toe, but also ankle, knee, or wrist) becomes abruptly swollen, red, hot, and exquisitely tender, often overnight. Speed is the whole game: treatment begun within the first 24 hours shortens attacks dramatically.
The three first-line options, chosen based on your kidneys, stomach, heart, diabetes status, and other medications:
- Colchicine: most effective started early; modern low-dose regimens work as well as old high-dose ones with far fewer side effects.
- NSAIDs (naproxen, indomethacin, celecoxib): effective at full anti-inflammatory doses; avoided with kidney disease, ulcers, or certain heart conditions.
- Corticosteroids: prednisone by mouth, or a steroid injection directly into the joint; often the best choice when NSAIDs and colchicine aren’t safe.
Ice and elevation help. “Waiting it out” is a plan for a week of misery. Untreated flares typically last 7-14 days.
One critical rule: if you’re already taking a uric-acid-lowering medication when a flare hits, don’t stop it. Stopping and restarting causes uric acid swings that prolong and re-trigger attacks.
Phase 2: Lowering Uric Acid, the Actual Cure-Adjacent Part
Flare treatment is firefighting. Urate-lowering therapy (ULT) is fire prevention, and it’s where gout is actually won.
Why it works: gout exists because uric acid above its saturation point (about 6.8 mg/dL) crystallizes in joints. Hold blood levels below 6 mg/dL and existing crystals slowly dissolve; below 5 mg/dL is the target when tophi (crystal deposits under the skin) are present. No crystals, no flares.
Who needs ULT: guidelines strongly recommend it for anyone with two or more flares a year, tophi, or gout-related joint damage on imaging. It’s also worth discussing after even one flare when uric acid is very high, or with kidney disease or kidney stones.
The medications:
- Allopurinol: the first-line agent for most patients. Started low (typically 100 mg daily, lower in kidney disease) and titrated up, often to 300 mg or beyond, until the uric acid target is reached. Genetic testing (HLA-B*58:01) is advised before starting for patients of certain ancestries (including Han Chinese, Korean, Thai, and African American patients) to avoid a rare severe skin reaction.
- Febuxostat: an alternative when allopurinol isn’t tolerated or falls short, used with cardiovascular history in mind.
- Pegloticase: an infused enzyme for severe, treatment-resistant tophaceous gout.
The counterintuitive part: expect a flare when you start. As crystals begin dissolving, they can trigger attacks in the first months of ULT. This is the medication working, and it’s why rheumatologists co-prescribe low-dose colchicine or an NSAID as flare prophylaxis for the first 3-6 months. Not knowing this is the number one reason patients quit ULT, and the number one preventable gout mistake.
Treat-to-target, not set-and-forget: the dose isn’t right until your uric acid is at goal, which means checking levels and titrating. Millions of patients sit on 100 mg of allopurinol with a uric acid of 7.5 and conclude the drug “doesn’t work.” It was never dosed properly.
What About Diet?
Diet matters: limiting alcohol (especially beer), sugary drinks and fructose, and purine-heavy foods like organ meats and some seafood, while favoring low-fat dairy, coffee, and cherries. But its effect is modest, typically around 1 mg/dL of uric acid. Most people with established gout cannot diet their way below 6 mg/dL, because uric acid handling is predominantly genetic and renal. Diet is a supporting actor; medication is the lead. (Full breakdown in our companion article on gout causes and diet.)
Why See a Rheumatologist for Gout?
- Confirming the diagnosis: gout, pseudogout, and infection can look identical and are treated differently
- Titrating ULT properly to target, with flare prophylaxis handled
- Managing gout alongside kidney disease, heart disease, and interacting medications
- Tackling advanced disease: tophi, erosions, refractory cases
Gout care also happens to be nearly ideal for telemedicine: flares are visible on camera, treatment is adjusted between labs drawn near your home, and same-week access matters enormously for a disease where early treatment defines how bad the week gets.
Frequently Asked Questions
Start anti-inflammatory treatment (colchicine, an NSAID, or corticosteroids) within the first 24 hours of symptoms. Early treatment can shorten an attack from one to two weeks down to a few days. Ice and elevation help while medication takes effect.
Below 6 mg/dL for most patients, and below 5 mg/dL when tophi are present. At these levels, existing crystals gradually dissolve and new flares become progressively less likely, typically fading substantially within the first year of properly dosed therapy.
Usually, yes. Uric acid rises again when medication stops, and crystals re-form. Think of it like blood pressure treatment: the disease is controlled, not cured. Properly dosed, allopurinol is well tolerated by the large majority of patients for decades.
Because it’s working. Dissolving crystals can provoke flares during the first months of therapy, which is why guidelines recommend low-dose colchicine or NSAID prophylaxis alongside urate-lowering therapy initially. Don’t stop the medication. The flares fade as the crystal burden shrinks.
Make This Your Last Flare. See Dr. Dhillon by Video This Week.
If gout keeps circling back, the fix is a properly targeted plan, not another round of firefighting. Dr. Dhillon, a board-certified rheumatologist, sees new patients by secure video visit from your home, usually within the same week, with records and labs reviewed before every appointment and direct texting access between visits. No referral required. Video visits are available to patients located in California, with in-person care in Beverly Hills.
Book a Video Visit, or call for a 15 minute discovery call at +1 (949) 209-4716.
This article is for educational purposes and is not a substitute for personalized medical advice, diagnosis, or treatment. Always consult a qualified physician about your specific situation.
